HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
NCT02063724
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
HER-2 pulsed Dendritic Cell Vaccine
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
[object Object]